2014-11-13T21:25:55-06:00 2013-12-31 410746749 CLIFTONLARSONALLEN LLP 4250 N FAIRFAX DRIVE SUITE 1020 ARLINGTON VA 22203 990 2013-01-01 521224577 BIOTECHNOLOGY INDUSTRY ORGANIZATION BIOT 2029629200 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 JOANNE M DUNCAN CFO & SVP, FINANCE & ADMIN 2029629200 2014-11-13 1 DAVID TRIMNER P00444822 5712279500 2013 2015-11-30 17:44:51Z JAMES C GREENWOOD 1201 MARYLAND AVENUE SW NO 900 WASHINGTON DC 20024 95876290 0 X WWW.BIO.ORG X 1993 DC THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) MISSION IS TO SUPPORT THE BIOTECHNOLOGY INDUSTRY TO EXPAND THE BOUNDARIES OF SCIENCE TO BENEFIT MANKIND BY PROVIDING BETTER HEALTH CARE, ENHANCED AGRICULTURE AND A CLEANER AND SAFER ENVIRONMENT. IT IS BIO'S MISSION TO BE THE CHAMPION OF BIOTECHNOLOGY AND THE ADVOCATE OF OUR MEMBER ORGANIZATIONS BOTH LARGE AND SMALL. 114 114 203 221 341966 -51235 0 0 59883011 60759645 2400453 4800278 3959 20773 62287423 65580696 232395 664500 0 0 27075315 29774878 0 0 0 37619628 35737171 64927338 66176549 -2639915 -595853 65054922 66638973 26151093 26153882 38903829 40485091 X THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) REPRESENTS MORE THAN 1,000 COMPANIES AND ORGANIZATIONS IN WASHINGTON DC, STATE CAPITALS, AND INTERNATIONAL FORA. BIO IS FOUNDED ON THE PRINCIPLE THAT POLICY MUST NURTURE INNOVATION IN THE LIFE SCIENCES TO OVERCOME CHALLENGES IN HEALTH CARE, AGRICULTURE, INDUSTRY, AND THE ENVIRONMENT. OUR MEMBERS REPRESENT COMPANIES OFFERING A SPECTRUM OF BIOTECHNOLOGY APPLICATIONS ACROSS MAJOR SECTORS OF THE ECONOMY. BIO MEMBERS ALSO INCLUDE UNIVERSITIES, NONPROFITS, PATIENT GROUPS, AND OTHER ORGANIZATIONS THAT PLAY AN IMPORTANT ROLE IN THE FUTURE OF THE LIFE SCIENCES. BIO'S ACTIVITIES ARE BROKEN DOWN INTO TWO PROGRAMS - ADVOCACY AND SERVICES. 0 0 ADVOCACYBIO'S ADVOCACY EFFORTS REFLECT THE PRIORITIES IDENTIFIED BY THE BIO BOARD OF DIRECTORS AND THE FOUR SECTION GOVERNING BOARDS.THE BOARD OF DIRECTORS FOCUSES ON ISSUES OF IMPORTANCE TO ALL BIO MEMBERS, REGARDLESS OF THEIR SIZE OR TECHNOLOGY. THESE CROSS-CUTTING ADVOCACY ACCOMPLISHMENTS IN 2013 ARE LISTED BELOW: - SAFEGUARDED AND ADVANCED INTELLECTUAL PROPERTY PROTECTIONS, DOMESTICALLY AND INTERNATIONALLY.- FOSTERED A DIALOGUE ABOUT ETHICS AND PROACTIVELY ADVANCED THE SOCIALLY RESPONSIBLE USE OF BIOTECHNOLOGY.- PROMOTED INVESTMENT IN GOVERNMENT AND ACADEMIC RESEARCH.- PROMOTED COMPREHENSIVE REFORM OF THE U.S. TAX CODE TO SPUR INNOVATION AND INVESTMENT IN BIOTECHNOLOGY.- EXPANDED OUTREACH TO FOREIGN GOVERNMENTS AND INTERNATIONAL ENTITIES TO EDUCATE ON POLICY ISSUES OF IMPORTANCE TO THE BIOTECHNOLOGY INDUSTRY AND TO IMPROVE THE INVESTMENT AND REGULATORY CLIMATE FOR BIOTECH PRODUCTS.THE HEALTH SECTION 2013 ADVOCACY ACCOMPLISHMENTS:- INFLUENCED IMPROVEMENTS TO THE U.S. FOOD AND DRUG ADMINISTRATION'S (FDA'S) PROCESS FOR HUMAN DRUG REVIEW.- ENHANCED AND PROTECTED PATIENT ACCESS TO INNOVATIVE THERAPIES.- ADVOCATED FOR BIOSIMILARS POLICIES THAT PROTECT PATIENT SAFETY AND PROMOTE BIOMEDICAL INNOVATION.- PROMOTED DEVELOPMENT AND USE OF RESEARCH TOOLS, MOLECULAR DIAGNOSTICS AND PERSONALIZED THERAPIES. - ADVOCATED FOR POLICIES THAT FOSTER VACCINE INNOVATION AND PROMOTE PANDEMIC AND BIO-DEFENSE PREPAREDNESS.- INFLUENCED IMPROVEMENTS TO THE INTERNATIONAL ENVIRONMENT FOR BIOMEDICAL INNOVATION.THE EMERGING COMPANIES SECTION 2013 ADVOCACY ACCOMPLISHMENTS: - ADVANCED THE INTEREST OF EMERGING COMPANIES IN CAPITAL FORMATION AND FINANCIAL SERVICES POLICY.- ADVOCATED FOR TAX POLICIES SUPPORTING INNOVATIVE EMERGING COMPANIES.- ADVOCATED FOR THE REMOVAL OF BURDENSOME FINANCIAL REPORTING REGULATIONS ON EMERGING COMPANIES.- INFLUENCED BIO'S HEALTH CARE POLICIES TO REFLECT THE CONCERNS OF SMALL BIOTECHNOLOGY COMPANIES.THE FOOD & AGRICULTURE SECTION 2013 ADVOCACY ACCOMPLISHMENTS: - WORKED WITH THE ADMINISTRATION AND CONGRESS TO ADVANCE IMPROVEMENTS TO THE U.S. AND GLOBAL REGULATORY SYSTEMS IN AN EFFORT TO PROVIDE PREDICTABILITY IN REGULATORY DECISIONS. - COMPLETED WORK ON THE AG ACCORD, A COMPREHENSIVE, VOLUNTARY PRIVATE SECTOR LEGAL FRAMEWORK TO PROVIDE FOR A SEAMLESS TRANSITION TO AN OFF-PATENT MARKETPLACE. - WORKED WITH MEMBERS OF THE AGRICULTURAL VALUE CHAIN TO SUPPORT DOMESTIC AND INTERNATIONAL REGULATORY REFORM. - FOSTERED A DIALOGUE WITH CONSUMERS AIMED AT ADDRESSING CONCERNS ABOUT AG-BIOTECHNOLOGY. - CONDUCTED OUTREACH TO ENVIRONMENTAL, ANTI-HUNGER AND CORPORATE ENTITIES, AS WELL AS INTERNATIONAL OFFICIALS, TO ADVANCE UNDERSTANDING OF AGRICULTURE BIOTECHNOLOGY AND THE CHALLENGES RELATED TO UNPREDICTABLE REGULATORY SYSTEMS. - WORKED WITH AGRICULTURAL INDUSTRY ALLIES TO OPPOSE FEDERAL AND STATE-LEVEL INITIATIVES AIMED AT NEGATIVELY IMPACTING AG-BIOTECHNOLOGY. THE INDUSTRIAL & ENVIRONMENTAL SECTION 2013 ADVOCACY ACCOMPLISHMENTS: - ADVOCATED FOR CONGRESS TO PRESERVE THE RENEWABLE FUELS STANDARD.- ADVOCATED FOR FUNDING OF THE NAVY GREEN FLEET INITIATIVE AND DEFENSE BIOFUELS. - ADVOCATED FOR THE INTRODUCTION OF SEVERAL FAVORABLE PIECES OF TAX CREDIT LEGISLATION RELATING TO RENEWABLE CHEMICALS, ALGAE, CELLULOSIC AND OTHER ADVANCED BIOFUELS.- WORKED TO SECURE A ROBUST ENERGY TITLE IN FARM BILL REAUTHORIZATION PROPOSALS IN CONGRESS AND TO ENSURE IT WAS EXTENDED TO RENEWABLE CHEMICALS. - ADVOCATED FOR THE CERTIFICATION PROCESS FOR THE VOLUNTARY LABELING PROGRAM IN THE U.S. DEPARTMENT OF AGRICULTURE'S BIOPREFERRED PROGRAM. SERVICESBIO'S SERVICES INCLUDE CONFERENCES AND ACTIVITIES THAT BRING TOGETHER INDUSTRY PARTNERS AND INVESTORS FOR EVENTS RANGING FROM THE BIO INTERNATIONAL CONVENTION TO CONFERENCES FOR BUSINESS DEVELOPMENT EXECUTIVES. THE BIO INTERNATIONAL CONVENTION ATTRACTS OVER 15,000 OF THE MOST INFLUENTIAL BIOTECH AND PHARMA ATTENDEES FROM 65 COUNTRIES AND 49 U.S. STATES, INCLUDING 300 MEMBERS OF THE MEDIA, AND OFFERS THREE DAYS OF PROFESSIONAL AND BUSINESS DEVELOPMENT OPPORTUNITIES. THE NET INCOME FROM THE CONVENTION SUPPORTS OUR ADVOCACY, PUBLIC OUTREACH, AND OTHER MEMBER SERVICE ACTIVITIES. THE KEY ELEMENTS OF THE BIO INTERNATIONAL CONVENTION ARE EDUCATIONAL PROGRAMMING, EXHIBITION, THE BIO BUSINESS FORUM, AND NETWORKING EVENTS. THESE ELEMENTS PROVIDE AN OPPORTUNITY FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, ACADEMIC RESEARCH INSTITUTIONS, AND INVESTORS FROM AROUND THE WORLD TO LEARN ABOUT RECENT SCIENTIFIC AND POLICY DEVELOPMENTS, AND SCHEDULE ONE-ON-ONE MEETINGS TO DISCUSS POTENTIAL BUSINESS OPPORTUNITIES. IN 2013, THE BIO BUSINESS FORUM ALONE HELPED HOST A RECORD NUMBER OF 25,537 PARTNERING MEETINGS AMONG MORE THAN 2,000 COMPANIES, ALONG WITH SOME 150 COMPANY PRESENTATIONS.BEYOND THE CONVENTION, BIO SUPPORTS THE CAPITAL FORMATION AND BUSINESS DEVELOPMENT NEEDS OF HUNDREDS OF ITS INNOVATIVE MEMBER COMPANIES THROUGH A PORTFOLIO OF OTHER EVENTS. THESE PROGRAMS FACILITATE CRITICAL CAPITAL FORMATION AND PARTNERSHIPS, AND PROVIDE ACCESS TO PROFESSIONAL SERVICES. THROUGH THE YEAR, BIO HOSTS OR CO-HOSTS A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES THAT PROVIDE VENUES FOR MEMBER AND NON-MEMBER COMPANIES TO PRESENT NEW DATA, MEET AND PARTNER WITH FELLOW BIOTECH COMPANIES, AND ATTRACT FUNDING FROM INVESTORS AND OTHER ORGANIZATIONS.IN 2013, BIO ALSO HELD TWO SUCCESSFUL CONFERENCES FOCUSED ON THE NEEDS OF THE INDUSTRIAL BIOTECH COMMUNITY - THE BIO WORLD CONGRESS ON INDUSTRIAL BIOTECHNOLOGY AND BIOPROCESSING AND THE BIO PACIFIC RIM SUMMIT ON INDUSTRIAL BIOTECHNOLOGY AND BIOENERGY. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 155 0 203 1 1 1 1 IN 0 0 0 0 X 114 114 0 0 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 0 0 X JOANNE M DUNCAN 2029629200 1201 MARYLAND AVE SW STE 900 WASHINGTON DC 20024 ATWOODBRIAN MEMBER 2.00 X 0 0 0 BABLERMARTIN MEMBER 2.00 X 0 0 0 BEALLROBERT MEMBER 2.00 X 0 0 0 BEEMANDONALD MEMBER 2.00 X 0 0 0 CROWLEYJOHN MEMBER 2.00 X 0 0 0 DIPPMICHELLE MEMBER 2.00 X 0 0 0 GIOVANNETTIGLEN MEMBER 2.00 X 0 0 0 HA-NGOCTUAN MEMBER 2.00 X 0 0 0 HASNAINFAHEEM MEMBER 2.00 X 0 0 0 HATFIELDJEFFREY MEMBER 2.00 X 0 0 0 HINDMANANDREW MEMBER 2.00 X 0 0 0 KISSROBERT MEMBER 2.00 X 0 0 0 KOSACZBARBARA MEMBER 2.00 X 0 0 0 LEAHYEMER MEMBER 2.00 X 0 0 0 LEFFJONATHAN MEMBER 2.00 X 0 0 0 MATHERSEDWARD MEMBER 2.00 X 0 0 0 MCCAULEYGORDON MEMBER 2.00 X 0 0 0 MENDLEINJOHN MEMBER 2.00 X 0 0 0 ORWINJOHN MEMBER 2.00 X 0 0 0 OSTROVEJEFFREY MEMBER 2.00 X 0 0 0 PELTZSTUART MEMBER 2.00 X 0 0 0 PERKINSADELENE MEMBER 2.00 X 0 0 0 PETERSONKRISTINE MEMBER 2.00 X 0 0 0 PRUZANSKIMARK MEMBER 2.00 X 0 0 0 WALBERTTIMOTHY MEMBER 2.00 X 0 0 0 XANTHOPOULOSKLEANTHIS MEMBER 2.00 X 0 0 0 ZAKESBRADFORD MEMBER 2.00 X 0 0 0 BEERMARC MEMBER 2.00 X 0 0 0 BORISYALEXIS MEMBER 2.00 X 0 0 0 COHENRON MEMBER 2.00 X 0 0 0 DOERFLERDOUGLAS MEMBER 2.00 X 0 0 0 GOWENMAXINE MEMBER 2.00 X 0 0 0 HASTINGSPAUL MEMBER 2.00 X 0 0 0 HERNDONRUSSELL MEMBER 2.00 X 0 0 0 JUNIUSDANIEL MEMBER 2.00 X 0 0 0 KARSENPERRY MEMBER 2.00 X 0 0 0 KINGRACHEL BOARD CHAIR 2.00 X X 0 0 0 KOENIGSCOTT MEMBER 2.00 X 0 0 0 LESCHLYNICK MEMBER 2.00 X 0 0 0 MARAGANOREJOHN MEMBER 2.00 X 0 0 0 MATHERSTHOMAS MEMBER 2.00 X 0 0 0 MEDFORDRUSSELL MEMBER 2.00 X 0 0 0 MENTOSTEVEN MEMBER 2.00 X 0 0 0 MOCHKENNETH MEMBER 2.00 X 0 0 0 MORRISARLENE MEMBER 2.00 X 0 0 0 NARACHIMICHAEL MEMBER 2.00 X 0 0 0 RODELLTIMOTHY MEMBER 2.00 X 0 0 0 SANDSARTHUR MEMBER 2.00 X 0 0 0 SCHENKEINDAVID MEMBER 2.00 X 0 0 0 SHERWINSTEPHEN MEMBER 2.00 X 0 0 0 SLAOUIMONCEF MEMBER 2.00 X 0 0 0 VAN BOKKELENGIL MEMBER 2.00 X 0 0 0 VAN WARTHAROLD MEMBER 2.00 X 0 0 0 FERGUSONBRUCE MEMBER 2.00 X 0 0 0 FLINTJERRY MEMBER 2.00 X 0 0 0 GUTTERSONNEAL MEMBER 2.00 X 0 0 0 KREMERMATHIAS MEMBER 2.00 X 0 0 0 MEDERMATTHIAS MEMBER 2.00 1.00 X 0 0 0 PREUSSDAPHNE MEMBER 2.00 X 0 0 0 READNOURROBIN MEMBER 2.00 X 0 0 0 SHURDUTBRADLEY MEMBER 2.00 X 0 0 0 STEINERGERALD MEMBER 2.00 X 0 0 0 STOTISHRONALD MEMBER 2.00 X 0 0 0 SULLIVANEDDIE MEMBER 2.00 X 0 0 0 TERHORSTFRANK MEMBER 2.00 X 0 0 0 WELLSBARBARA MEMBER 2.00 X 0 0 0 WONGMARK MEMBER 2.00 X 0 0 0 ADAMSADRIAN MEMBER 2.00 X 0 0 0 APELDANIEL MEMBER 2.00 X 0 0 0 ARBUCKLESTUART MEMBER 2.00 X 0 0 0 AZARALEX MEMBER 2.00 X 0 0 0 BIENAIMEJEAN-JACQUES MEMBER 2.00 X 0 0 0 BORMANNBJ MEMBER 2.00 X 0 0 0 CLARKIAN MEMBER 2.00 X 0 0 0 COLESN MEMBER 2.00 X 0 0 0 CROOKESTANLEY MEMBER 2.00 X 0 0 0 DOLIVEUXROCH MEMBER 2.00 X 0 0 0 DUNCANGREG MEMBER 2.00 X 0 0 0 DUNSIREDEBORAH MEMBER 2.00 X 0 0 0 FITZSIMMONSWILLIAM MEMBER 2.00 X 0 0 0 GERBERDINGJULIE MEMBER 2.00 X 0 0 0 GERMANOGENO MEMBER 2.00 X 0 0 0 GORMLEYGLENN MEMBER 2.00 X 0 0 0 GREENLEAFPETER MEMBER 2.00 X 0 0 0 HANTSONLUDWIG MEMBER 2.00 X 0 0 0 HOLTZMANSTEVEN MEMBER 2.00 X 0 0 0 HOPPENOTHERVE MEMBER 2.00 X 0 0 0 HOYESJAMES MEMBER 2.00 X 0 0 0 HUDSONPAUL MEMBER 2.00 X 0 0 0 JENKINSANNALISA MEMBER 2.00 X 0 0 0 JOHNSONJOHN MEMBER 2.00 X 0 0 0 KARSENPERRY MEMBER 2.00 X 0 0 0 LEIDENJEFFREY MEMBER 2.00 X 0 0 0 LEONARDJOHN MEMBER 2.00 X 0 0 0 LUNDBERGJAN MEMBER 2.00 X 0 0 0 MANUSOJAMES MEMBER 2.00 X 0 0 0 MCHUGHJULIE MEMBER 2.00 X 0 0 0 MEEKERDAVID MEMBER 2.00 X 0 0 0 MILLIGANJOHN MEMBER 2.00 X 0 0 0 NADERFRANCOIS MEMBER 2.00 X 0 0 0 NICOLAIDESNICHOLAS MEMBER 2.00 X 0 0 0 ORWINJOHN MEMBER 2.00 X 0 0 0 PETERSONKRISTINE MEMBER 2.00 X 0 0 0 POPSRICHARD MEMBER 2.00 X 0 0 0 PROTOPAPASANNA MEMBER 2.00 X 0 0 0 PYOTTDAVID SECRETARY 2.00 X X 0 0 0 ROBINHOWARD MEMBER 2.00 X 0 0 0 RYDERSTEVEN MEMBER 2.00 X 0 0 0 SACCHETTIRAYMOND MEMBER 2.00 X 0 0 0 SCHUMACHERLAURA MEMBER 2.00 X 0 0 0 SIEGELJAY MEMBER 2.00 X 0 0 0 SKALETSKYMARK TREASURER 2.00 X X 0 0 0 TASSEDANIEL MEMBER 2.00 X 0 0 0 TERMEERHENRI MEMBER 2.00 X 0 0 0 VERWIELFRANK MEMBER 2.00 X 0 0 0 WATKINSH THOMAS MEMBER 2.00 X 0 0 0 WAXMANALLEN MEMBER 2.00 X 0 0 0 WILGENBUSKLAUS MEMBER 2.00 X 0 0 0 BERVENDOUG MEMBER 2.00 X 0 0 0 COLLINSJAMES MEMBER 2.00 X 0 0 0 CUMMINGSDANIEL MEMBER 2.00 X 0 0 0 EGGERTCHARLES MEMBER 2.00 X 0 0 0 ELLERBUSCHSUSAN MEMBER 2.00 X 0 0 0 ENORICHARD MEMBER 2.00 X 0 0 0 FEEHERYWILLIAM MEMBER 2.00 X 0 0 0 FRITZCAROLYN MEMBER 2.00 X 0 0 0 GATTOSTEPHEN MEMBER 2.00 X 0 0 0 GRUBERPATRICK MEMBER 2.00 X 0 0 0 LEVINEJAMES MEMBER 2.00 X 0 0 0 MONROEADAM MEMBER 2.00 X 0 0 0 OZMERALCENAN MEMBER 2.00 X 0 0 0 RATHANNA MEMBER 2.00 X 0 0 0 STANDLEECHRISTOPHER MEMBER 2.00 X 0 0 0 TANDASTEPHAN MEMBER 2.00 X 0 0 0 TAYLORTHOMAS MEMBER 2.00 X 0 0 0 THAKRARATUL MEMBER 2.00 X 0 0 0 TUTTLESTEVEN MEMBER 2.00 X 0 0 0 VERBRUGGENMARC MEMBER 2.00 X 0 0 0 VITTERSSCOTT MEMBER 2.00 X 0 0 0 WELLSBARBARA MEMBER 2.00 X 0 0 0 WOLFSONJONATHAN MEMBER 2.00 X 0 0 0 WYSEROGER MEMBER 2.00 X 0 0 0 ZULLOJILL MEMBER 2.00 X 0 0 0 GREENWOOD JAMES CEO & PRESIDENT 40.00 X 1686632 0 1415304 DUNCAN JOANNE CFO & SVP, FINANCE & ADMIN 40.00 X 418595 0 59680 WHITAKER A SCOTT COO 40.00 X 793165 0 143933 DILENGE THOMAS GENERAL COUNSEL & HEAD OF PUBLIC POLICY 40.00 X 548588 0 58247 BITTENBENDER FREDERICK EVP, PUBLIC AFFAIRS 40.00 X 480574 0 68769 ENRIGHT CATHLEEN EVP, FOOD & AGRICULTURE 40.00 X 315318 0 53930 ERICKSON BRENT EVP, INDUSTRIAL & ENVIRONMENTAL 40.00 X 449666 0 51464 ESHAM CARTIER EVP, EMERGING COMPANIES 40.00 X 203693 0 31580 RADCLIFFE SARA EVP, HEALTH 40.00 X 487802 0 47939 FINAN AMY SVP, BUSINESS DEVELOPMENT 40.00 X 383799 0 48450 DAMOND JOSEPH SVP, INTERNATIONAL AFFAIRS 40.00 X 426137 0 58802 DELMONTE BRENT SVP, FEDERAL GOVERNMENT RELATIONS 40.00 X 503945 0 47784 LISAIUS KENNETH SVP, COMMUNICATIONS 40.00 X 330480 0 52228 LYCETT ROBERTA SVP, CONVENTIONS & CONFERENCES 40.00 X 365047 0 53576 EISENBERG ALAN EXEC VP, EMERGING COMPANIES 40.00 X 580725 0 25420 7974166 0 2217106 68 0 1 0 FREEMAN COMPANIES PO BOX 660613 DALLAS TX 75266 CONVENTION & CONFERENCES GENERAL CONTRAC 1781549 PROJECTION INC PO BOX 890472 CHARLOTTE NC 28289 VIDEO SERVICES FOR CONVENTION & CONFEREN 878885 SMG FOOD & BEVERAGE LLC 600 EAST GRAND AVE ROAD CHICAGO IL 60611 FOOD SERVICE FOR INTERNATIONAL CONVENTIO 676169 ALBRIGHT STONEBRIDGE GROUP LLC 555 13TH STREET NW SUITE 300W WASHINGTON DC 20004 CONSULTANT SERVICES 557477 FUELS AMERICA 101 CONSTITUTION AVE NW SUITE 525 WASHINGTON DC 20001 CONSULTANT SERVICES 500357 78 CONFERENCE/MEETING REVENUE 541800 31912396 31626853 285543 MEMBERSHIP DUES 900099 24129370 24129370 BUSINESS SOLUTIONS 900099 4679709 4679709 PUBLICATION ADVERTISING 541800 38170 170 38000 60759645 1667575 1667575 33428297 30295594 3132703 3132703 3132703 JOB BOARD REVENUE 900099 18423 18423 MISCELLANEOUS REVENUE 900099 2350 2350 20773 65580696 55756393 341966 9482337 664500 7747130 17373566 1636747 2164700 852735 535226 59737 1819716 328235 5812427 174669 1787673 829782 4005094 1326654 15680834 4029 1897773 895774 112254 OUTREACH 239775 TAXES PAID 73568 BAD DEBT EXPENSE 54500 COMPANY EVENTS 53692 45759 66176549 2528659 1370438 3117733 2836623 2423170 1511943 10170033 7663131 3294080 2506902 53510015 58266627 181265 146440 65054922 66638973 9709497 11686388 10570025 8913117 5871571 5554377 26151093 26153882 X 38903829 40485091 38903829 40485091 65054922 66638973 X -595853 1956065 221050 X 0 1 X 1 0 0 0 1 24129370 7970000 26386 7996386 7963000 33386 5988846 3701037 2287809 1809191 1732202 76989 2371996 2229892 142104 2506902 CAPITAL LEASE OBLIGATION 70136 DEFERRED RENT 5484241 5554377 X 68486716 1956065 1288190 3244255 65242461 338235 338235 65580696 66905454 1067140 1067140 65838314 338235 338235 66176549 PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(6) OF THE INTERNAL REVENUE CODE AS A SECTION 501(A) ORGANIZATION. HOWEVER, THE ORGANIZATION IS SUBJECT TO FEDERAL AND DISTRICT OF COLUMBIA TAXES ON ITS UNRELATED BUSINESS INCOME. THE ORGANIZATION'S TAX RETURNS ARE SUBJECT TO REVIEW AND EXAMINATION BY FEDERAL, STATE AND LOCAL AUTHORITIES. THE TAX RETURNS FOR THE FISCAL YEARS ENDED 2010 TO 2012 ARE OPEN FOR EXAMINATION BY FEDERAL, STATE AND LOCAL AUTHORITIES. PART XI, LINE 2D - OTHER ADJUSTMENTS: CBI 39,908. CBI LOBBYING FUND 790,000. FOOD & AG INITIATIVES REVENUE 110,556. FOOD & AG LEGAL FUND 16,219. BIOSIMILARS REVENUE 331,507. PART XII, LINE 2D - OTHER ADJUSTMENTS: BIOSIMILAR EXPENSES 216,474. CBI LOBBYING FUND 834,447. FOOD & AG LEGAL FUND 16,219. EUROPE 0 1 PROGRAM SERVICES CONFERENCES AND ADVOCACY 313355 SOUTH ASIA 0 1 PROGRAM SERVICES CONFERENCES AND ADVOCACY 81201 EAST ASIA AND THE PACIFIC 0 9 PROGRAM SERVICES CONFERENCES AND ADVOCACY 1116468 NORTH AMERICA 0 0 PROGRAM SERVICES CONFERENCES AND ADVOCACY 882755 SOUTH AMERICA 0 0 PROGRAM SERVICES ADVOCACY 57648 RUSSIA & THE NEWLY INDEPENDENT STATES 0 0 PROGRAM SERVICES ADVOCACY 3525 MIDDLE EAST & NORTH AFRICA 0 0 PROGRAM SERVICES ADVOCACY 41871 0 11 0 0 0 11 2496823 0 2496823 0 0 0 0 0 0 0 ALLIANCE FOR A STRONGER FDA PO BOX 7508 SILVER SPRING MD 209077508 204669553 501(C)(4) 25000 GENERAL SUPPORT NEHI ONE BROADWAY 15TH FLOOR CAMBRIDGE MA 02142 010624865 501(C)(3) 25000 GENERAL SUPPORT NATIONAL COALITION FOR CANCER SURVIVORSHIP 1010 WAYNE AVENUE SUITE 770 SILVER SPRING MD 20910 850357897 501(C)(3) 15000 GENERAL SUPPORT BIOFLORIDA INC 525 OKEECHOBEE BLVD STE 1500 WEST PALM BEACH FL 33401 593436638 501(C)(6) 5500 GENERAL SUPPORT UTAH FAMILIES FOUNDATION 9160 SOUTH 300 WEST 21 SANDY UT 84070 870509416 501(C)(3) 5000 GENERAL SUPPORT GLOBAL HEALTHY LIVING FOUNDATION INC 515 NORTH MIDLAND AVE UPPER NYACK NY 10960 204039120 501(C)(3) 15000 GENERAL SUPPORT NATIONAL MINORITY QUALITY FORUM INC 1200 NEW HAMPSHIRE AVENUE NW STE 575 WASHINGTON DC 20036 311750942 501(C)(3) 10000 GENERAL SUPPORT NATIONAL HEALTH COUNCIL 1730 M STREET NW SUITE 500 WASHINGTON DC 200364561 131624107 501(C)(3) 7500 GENERAL SUPPORT EVERYLIFE FOUNDATION FOR RARE DISEASES 750 9TH STREET NW SUITE 750 WASHINGTON DC 20001 264614274 501(C)(3) 10000 GENERAL SUPPORT PARKINSON'S ACTION NETWORK 1025 VERMONT AVE SUITE 1120 WASHINGTON DC 20005 943172675 501(C)(3) 6500 GENERAL SUPPORT MELANOMA RESEARCH ALLIANCE FOUNDATION 1101 NEW YORK AVE SUITE 620 WASHINGTON DC 20006 261636099 501(C)(3) 5000 GENERAL SUPPORT LEUKEMIA & LYMPHOMA SOCIETY 5845 RICHMOND HWY SUITE 800 ALEXANDRIA VA 22303 135644916 501(C)(3) 125000 GENERAL SUPPORT AMERICAN CANCER SOCIETY 101 YGNACIO VALLEY ROAD SUITE 110 WALNUT CREEK CA 94596 131788491 501(C)(3) 35000 GENERAL SUPPORT LUPUS RESEARCH INSTITUTE INC 330 7TH AVE SUITE 1701 NEW YORK NY 10001 061565950 501(C)(3) 5000 GENERAL SUPPORT SOCIETY FOR WOMENS HEALTH P O BOX 791139 BALTIMORE MD 212791139 521694732 501(C)(3) 15000 GENERAL SUPPORT NATIONAL ORGANIZATION FOR RARE DISORDERS INC 55 KENOSIA AVENUE DANBURY CT 06810 133223946 501(C)(3) 10000 GENERAL SUPPORT MANHATTAN INSTITUTE FOR POLICY RESEARCH INC 52 VANDERBILT AVE NEW YORK NY 10017 132912529 501(C)(3) 5000 GENERAL SUPPORT LUPUS FOUNDATION OF AMERICA INC PO BOX 139 UTICA NY 13503 161083229 501(C)(3) 5000 GENERAL SUPPORT ALLIANCE FOR PATIENT ACCESS 6227 EAGLE RIDGE ROAD BETTENDORF IA 52722 205130312 501(C)(4) 50000 GENERAL SUPPORT TRANSPLANT FOUNDATION INC 701 SW 27TH AVENUE SUITE 705 MIAMI FL 33135 592767754 501(C)(3) 50000 GENERAL SUPPORT NATIONAL ALLIANCE FOR CAREGIVING 4720 MONTGOMERY LANE SUITE 205 BETHESDA MD 20814 521931357 501(C)(3) 5000 GENERAL SUPPORT FOUNDATION TO ERADICATE DUCHENNE INC PO BOX 2371 ALEXANDRIA VA 22301 710874241 501(C)(3) 10000 GENERAL SUPPORT ALLIANCE FOR AGING RESEARCH 750 17TH ST NW-STE 110 WASHINGTON DC 20006 541379174 501(C)(3) 10000 GENERAL SUPPORT FRIENDS OF CANCER RESEARCH 1800 M STREET NW SUITE 1050 SOUTH WASHINGTON DC 20036 521983273 501(C)(3) 5000 GENERAL SUPPORT NATIONAL MULTIPLE SCIEROSIS SOCIETY 1800 M STREET NW SUITE 7505 WASHINGTON DC 20036 530237585 501(C)(3) 5000 GENERAL SUPPORT RARE PROJECT 28 ARGONAUT SUITE 150 ALISO VUEJO CA 92656 263331487 501(C)(3) 15000 GENERAL SUPPORT ZERO - THE PROJECT TO END PROSTATE CANCER 10 G STREET NE SUITE 601 WASHINGTON DC 20002 593400922 501(C)(3) 5000 GENERAL SUPPORT COLON CANCER ALLIANCE INC 1025 VERMONT AVE SUITE 1066 WASHINGTON DC 20005 860947831 501(C)(3) 5000 GENERAL SUPPORT THE MILKEN INSTITUTE 1250 FOURTH STREET 2ND FLOOR SAN MONICA CA 90401 954240775 501(C)(3) 25000 GENERAL SUPPORT MICHAEL J FOX FOUNDAITON FOR PARKINSON RESEARCH 498 SEVEN AVENUE 18TH FLOOR NEW YORK NY 10018 134141945 501(C)(3) 5000 GENERAL SUPPORT SARCOMA FOUNDATION OF AMERICA INC 9899 MAIN STREET SUITE 204 DAMASCUS MD 20872 522275294 501(C)(3) 5000 GENERAL SUPPORT NATIONAL ALLIANCE ON MENTAL ILLNESS 3803 N FAIRFAX DR SUITE 100 ARLINGTON VA 22203 431201653 501(C)(3) 5000 GENERAL SUPPORT ACCC 11600 NEBEL ST SUITE 201 ROCKVILLE MD 208522557 510137807 501(C)(3) 5000 GENERAL SUPPORT ALLIANCE FOR SAFE BIOLOGICAL MEDICINES PO BOX 3691 ARLINGTON VA 22203 274413226 501(C)(4) 75000 GENERAL SUPPORT THE CONGRESSIONAL HUNGER CENTER 400 N CAPITOL ST NW SG100 WASHINGTON DC 20001 521842738 501(C)(3) 10000 GENERAL SUPPORT COMPETITIVE ENTERPRISE INSTITUTE 1899 L ST NW 12TH FLOOR WASHINGTON DC 20036 521351785 501(C)(3) 10000 GENERAL SUPPORT WASHINGTON LEGAL FOUNDATION 2009 MASSACHUSETTS AVENUE NW WASHINGTON DC 20036 521071570 501(C)(3) 10000 GENERAL SUPPORT AMERICAN ENTERPRISE INSTITUTE FOR PUBLIC POLICY RESEARCH 1150 17TH STREET NW WASHINGTON DC 20036 530218495 501(C)(3) 40000 GENERAL SUPPORT 34 4 X X X 1 1 X X X X X X 0 1 0 GREENWOOD JAMES CEO & PRESIDENT 1000800 0 660000 0 25832 0 1383960 0 31344 0 3101936 0 0 0 DUNCAN JOANNE CFO & SVP, FINANCE & ADMIN 310055 0 108540 0 0 0 32110 0 27570 0 478275 0 0 0 WHITAKER A SCOTT COO 587371 0 205794 0 0 0 117858 0 26075 0 937098 0 0 0 DILENGE THOMAS GENERAL COUNSEL & HEAD OF PUBLIC POL 406252 0 142336 0 0 0 32110 0 26137 0 606835 0 0 0 BITTENBENDER FREDERICK EVP, PUBLIC AFFAIRS 360874 0 119700 0 0 0 32110 0 36659 0 549343 0 0 0 ENRIGHT CATHLEEN EVP, FOOD & AGRICULTURE 259905 0 55413 0 0 0 32110 0 21820 0 369248 0 0 0 ERICKSON BRENT EVP, INDUSTRIAL & ENVIRONMENTAL 348401 0 101265 0 0 0 32110 0 19354 0 501130 0 0 0 ESHAM CARTIER EVP, EMERGING COMPANIES 179193 0 24500 0 0 0 24345 0 7235 0 235273 0 0 0 RADCLIFFE SARA EVP, HEALTH 361266 0 126536 0 0 0 32110 0 15829 0 535741 0 0 0 FINAN AMY SVP, BUSINESS DEVELOPMENT 291006 0 92793 0 0 0 32110 0 16340 0 432249 0 0 0 DAMOND JOSEPH SVP, INTERNATIONAL AFFAIRS 322814 0 103323 0 0 0 32110 0 26692 0 484939 0 0 0 DELMONTE BRENT SVP, FEDERAL GOVERNMENT RELATIONS 377451 0 126494 0 0 0 32110 0 15674 0 551729 0 0 0 LISAIUS KENNETH SVP, COMMUNICATIONS 270480 0 60000 0 0 0 29561 0 22667 0 382708 0 0 0 LYCETT ROBERTA SVP, CONVENTIONS & CONFERENCES 282551 0 82496 0 0 0 32110 0 21466 0 418623 0 0 0 EISENBERG ALAN EXEC VP, EMERGING COMPANIES 432246 0 148479 0 0 0 3801 0 21619 0 606145 0 0 0 PART I, LINE 1A JAMES GREENWOOD - PERSONAL TRANSPORTATION - $21,832 - TRAVEL FOR COMPANIONS - $4,000 THE ABOVE ITEMS WERE INCLUDED IN THE TAXABLE INCOME OF THE INDIVIDUAL. PART I, LINE 4B JAMES GREENWOOD - 457(F) $1,383,960 SCOTT WHITAKER - 457(F) $85,478 FORM 990, PART VI, SECTION A, LINE 1 THE BOARD OF DIRECTORS SHALL DESIGNATE, BY RESOLUTION AND WITH A QUORUM PRESENT, NOT MORE THAN NINETEEN (19) DIRECTORS OF THE BOARD TO ACT AS AN EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL CONSIST OF THE SEVEN (7) ELECTED OFFICERS OF THE ORGANIZATION (AS DEFINED IN ARTICLE VIII); THE IMMEDIATE PAST CHAIR OF THE ORGANIZATION; THE VICE CHAIRS OF EACH SECTION'S GOVERNING BOARD; AND THE BALANCE BEING AT-LARGE DIRECTORS FROM THE FULL BOARD. IF THE IMMEDIATE PAST CHAIR IS NO LONGER ELIGIBLE TO SERVE ON THE FULL BOARD, AN ADDITIONAL AT-LARGE DIRECTOR FROM THE FULL BOARD SHALL BE SELECTED FOR THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE SHALL HAVE, AND BE AUTHORIZED TO EXERCISE, ALL POWERS OF THE FULL BOARD, EXCEPT: (A) THE POWER TO ELECT OR REMOVE ELECTED OFFICERS OR DIRECTORS, TO CHANGE THE SIZE OF THE BOARD, TO CHANGE ELIGIBILITY, QUALIFICATIONS OR RIGHTS OF MEMBERSHIP, TO APPROVE THE FINANCIAL BUDGET FOR THE ORGANIZATION, OR TO MAKE DETERMINATIONS AS TO DIRECTOR AND OFFICER COMPENSATION, WHERE APPLICABLE; AND (B) THE POWER TO AMEND THE ARTICLES OF INCORPORATION OR THE BYLAWS OF THE ORGANIZATION. FORM 990, PART VI, SECTION A, LINE 6 THE MEMBERS OF THE ORGANIZATION SHALL BE DIVIDED INTO FOUR CLASSES; CORE MEMBERS, ASSOCIATE MEMBERS, AFFILIATE MEMBERS, AND CENTER MEMBERS, DEFINED AS FOLLOWS: (A) CORE MEMBERS. ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PERCENTAGE OF WHOSE BUSINESS ACTIVITIES INVOLVE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR RELATED NEW TECHNOLOGIES, IS ELIGIBLE FOR MEMBERSHIP. CORE MEMBERS ARE THOSE ENTITIES THAT UTILIZE BIOTECHNOLOGY, GENOMICS, BIOINFORMATICS OR OTHER RELATED NEW TECHNOLOGIES IN RESEARCH, DEVELOPMENT, TESTING, MANUFACTURING, OR SALES OF PRODUCT OR INFORMATION, AS WELL AS OTHER FIRMS THE BOARD SO CHARACTERIZES AND PLACES IN THIS CATEGORY. CORE MEMBERS SHALL BE GROUPED IN THE FOLLOWING SUBCATEGORIES: (I) EMERGING COMPANIES, WHICH ARE FIRMS THAT EMPLOY LESS THAN 350 PERSONS AND THAT DO NOT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; (II) ESTABLISHED FIRMS, WHICH ARE THOSE FIRMS THAT EMPLOY 350 OR MORE PERSONS OR THAT HAVE A THERAPEUTIC OR DIAGNOSTIC PRODUCT APPROVED FOR SALE IN THE U.S. MARKET; AND (III) LARGE FIRMS, WHICH ARE ESTABLISHED FIRMS THAT HAVE ANNUAL WORLDWIDE SALES OF BIOTECHNOLOGY PRODUCTS IN EXCESS OF $1.5 BILLION; AND (IV) NON-DOMESTIC COMPANIES, WHICH ARE CORE MEMBERS WITHOUT SIGNIFICANT OPERATIONS IN THE UNITED STATES OR SIGNIFICANT COLLABORATIONS WITH A U.S. ENTITY. (B) ASSOCIATE MEMBERS. ANY CORPORATION, PARTNERSHIP, ASSOCIATION, OR OTHER ENTITY ORGANIZED FOR PROFIT, A SUBSTANTIAL PORTION OF WHOSE ACTIVITIES INVOLVE PROVIDING SERVICES OR PRODUCTS OF BENEFIT TO COMPANIES WHOSE PRINCIPAL BUSINESS IS BIOTECHNOLOGY, IS ELIGIBLE FOR ASSOCIATE MEMBERSHIP. ASSOCIATE MEMBERS ARE THOSE COMMERCIAL ENTITIES WHICH DO NOT NECESSARILY UTILIZE BIOTECHNOLOGY; E.G. TECHNICAL SUPPORT, EQUIPMENT, CONSTRUCTION, ACCOUNTING, AND LAW FIRMS THAT SERVICE THE BIOTECHNOLOGY INDUSTRY, AS WELL AS OTHER FIRMS THAT THE BOARD CHARACTERIZES AND PLACES IN THIS CATEGORY. (C) AFFILIATE MEMBERS. ANY GOVERNMENTAL OR NONPROFIT ENTITY OR COUNTRY, STATE OR REGIONAL INDUSTRY, TRADE OR PROFESSIONAL ASSOCIATION WITH AN INTEREST IN, OR A MANDATE TO PROMOTE THE DEVELOPMENT OF, BIOTECHNOLOGY IS ELIGIBLE FOR AFFILIATE MEMBERSHIP. THERE SHALL BE NO SIZE TESTS APPLIED TO AFFILIATE MEMBER APPLICANTS. (D) CENTER MEMBERS. ANY INSTITUTION, NOT GENERALLY ELIGIBLE FOR CORE MEMBERSHIP THAT IS SPONSORED BY A STATE, REGION, OR ACADEMIC INSTITUTION AND WORKS IN SUPPORT OF COMMERCIAL BIOTECHNOLOGY MAY BE ELIGIBLE FOR CONSIDERATION AS A CENTER MEMBER. FORM 990, PART VI, SECTION A, LINE 7A AT ALL MEMBERSHIP MEETINGS OF THE ORGANIZATION, EACH CURRENT MEMBER SHALL HAVE ONE (1) VOTE AND MAY TAKE PART IN THE VOTING IN PERSON OR BY PROXY. FOR EACH SECTION IN WHICH THE MEMBER PARTICIPATES, EACH MEMBER SHALL HAVE THE RIGHT TO VOTE ON THE ELECTION OF DIRECTORS FOR THE SECTION GOVERNING BOARD, BUT SHALL HAVE NO OTHER VOTING RIGHTS EXCEPT ON MATTERS BROUGHT TO THE MEMBERSHIP BY ANY SUCH GOVERNING BOARD OR THE ORGANIZATION'S BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 AND RELATED SCHEDULES ARE PREPARED BY THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS UNDER THE GUIDANCE OF THE CFO. THE CFO AND THE CONTROLLER THOROUGHLY REVIEW ALL CALCULATIONS AND SCHEDULES TO CONFIRM THEY REFLECT THE ACTUAL FINANCIAL RESULTS OF THE ORGANIZATION. THE COMPLETE FORM 990 IS THEN REVIEWED INTERNALLY BY THE CEO, COO, CFO, AND CONTROLLER IN CONSULTATION WITH LEGAL COUNSEL AND, AS APPROPRIATE, FURTHER CONSULTATION WITH THE ORGANIZATION'S CERTIFIED PUBLIC ACCOUNTANTS. FINALLY, THE FORM 990 IS PROVIDED TO THE CHAIRMAN OF THE BOARD AND BIO EXECUTIVE COMMITTEE MEMBERS FOR THEIR REVIEW, QUESTIONS AND/OR COMMENTS. ALL REVIEWS ARE COMPLETED BEFORE THE FORM IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C BIO TAKES SEVERAL STEPS TO ADDRESS COMPLIANCE BY EMPLOYEES AND DIRECTORS WITH ITS CONFLICTS OF INTEREST POLICY. BIO TRAINS ALL NEW EMPLOYEES AND DIRECTORS ON VARIOUS ASPECTS OF BIO'S COMPLIANCE PROGRAM, INCLUDING CONFLICTS OF INTEREST, AND BIO'S WRITTEN CONFLICTS OF INTEREST POLICY REQUIRES ALL EMPLOYEES TO DISCLOSE ANY OUTSIDE PERSONAL BUSINESS INTERESTS TO THEIR SUPERVISOR. BIO'S GENERAL COUNSEL REGULARLY ADVISES BIO'S EXECUTIVES AND SUPERVISORS ON SUCH MATTERS. BIO ALSO CONTRACTS WITH AN INDEPENDENT ORGANIZATION TO PROVIDE EMPLOYEES AND OTHERS WITH THE ABILITY TO FILE ANONYMOUS REPORTS CONCERNING THE VIOLATION OF ANY LAWS OR BIO POLICIES, INCLUDING ALLEGATIONS OF POTENTIAL CONFLICTS OF INTEREST, AND BIO HAS A PROCESS IN PLACE TO FOLLOW UP ON ANY SUCH COMPLAINTS IN A TIMELY AND THOROUGH MANNER. FURTHER, BIO UNDERTAKES A QUESTIONNAIRE SENT TO EACH MEMBER OF ITS BOARD OF DIRECTORS SEEKING DISCLOSURE OF ANY POTENTIAL CONFLICTS OF INTERESTS THEY MAY HAVE, OR THEIR FAMILY MEMBERS MAY HAVE, ASSOCIATED WITH BUSINESSES OR ORGANIZATIONS THAT DO BUSINESS WITH BIO. POTENTIAL CONFLICTS ARE MONITORED AND REVIEWED AT THE MANAGEMENT AND SENIOR MANAGEMENT LEVEL OF THE ORGANIZATION, AND DEPENDING ON THE CONFLICT, DETERMINATIONS MAY BE MADE AT THE BOARD OR SENIOR MANAGEMENT LEVEL. A CONFLICT AT THE BOARD LEVEL WILL NORMALLY RESULT IN RECUSAL OF THE INDIVIDUAL FROM PARTICIPATION OR ACTIVITIES WITH RESPECT TO THE RELEVANT SUBJECT MATTER. AT THE STAFF LEVEL, THE APPLICABLE BIO SUPERVISOR IS INFORMED OF THE POTENTIAL CONFLICT AND IS REQUIRED TO TAKE ALL APPROPRIATE STEPS TO ENSURE THAT THE INDIVIDUAL DOES NOT PARTICIPATE IN, OR RECEIVE CONFIDENTIAL INFORMATION RELATING TO, ANY BIO ACTIVITY RELATED TO THE SUBJECT MATTER OF THE CONFLICT, UP TO AND INCLUDING, WHERE APPROPRIATE, TERMINATION OF SUCH EMPLOYEE. FORM 990, PART VI, SECTION B, LINE 15A THE PERFORMANCE AND COMPENSATION OF THE PRESIDENT AND CEO OF BIO FOR 2013 WAS REVIEWED AND DETERMINED IN A PROCESS THAT WAS LED BY THE CHAIRMAN OF THE BOARD AND INVOLVED THE FULL EXECUTIVE COMMITTEE OF THE BOARD. THE BIO EXECUTIVE COMMITTEE, WHICH IS COMPRISED OF INDEPENDENT BIO BOARD MEMBERS, LEADS AND UNDERTAKES THIS ANNUAL PROCESS. IF NEEDED IN CARRYING OUT THIS PROCESS, THE MEMBERS OF THE EXECUTIVE COMMITTEE CAN BE ASSISTED AND COUNSELED BY BOTH INDEPENDENT OUTSIDE LEGAL COUNSEL WHO IS AN EXPERT IN THIS AREA OF THE LAW, AND AN INDEPENDENT OUTSIDE CONSULTANT THAT PROVIDES BENCHMARKING SERVICES AND INFORMATION ON EXECUTIVE COMPENSATION ISSUES. THE UNDERLYING EXECUTIVE EMPLOYMENT AGREEMENT WAS REVISED AND EXTENDED IN 2011, IN CONSULTATION WITH EXTERNAL INDEPENDENT LEGAL AND COMPENSATION CONSULTANTS AND WITH THE FULL BOARD OF DIRECTORS, AND WITH FINAL APPROVAL BY THE EXECUTIVE COMMITTEE OF THE BOARD. BASED ON THE EXECUTIVE COMMITTEE'S EVALUATION OF THE PRESIDENT AND CEO'S PERFORMANCE FOR 2013, THE COMMITTEE DETERMINED THE APPROPRIATE AMOUNT FOR THE DISCRETIONARY COMPONENT OF HIS COMPENSATION FOR THAT YEAR, IN ACCORDANCE WITH PROVISIONS OF THE EXECUTIVE AGREEMENT. FORM 990, PART VI, SECTION B, LINE 15B: DECISIONS REGARDING THE COMPENSATION FOR OFFICERS AND KEY EMPLOYEES OF THE ORGANIZATION ARE NEGOTIATED INDIVIDUALLY AND ARE PERFORMANCE-BASED, IN ACCORDANCE WITH AN ANNUAL WRITTEN EVALUATION PROCESS THAT HAS BEEN ESTABLISHED FOR ALL EMPLOYEES OF THE ORGANIZATION. THE CHIEF OPERATING OFFICER LEADS AND UNDERTAKES THIS PROCESS, IN COORDINATION WITH THE PRESIDENT & CEO. AN INDEPENDENT CONSULTANT PROVIDES COMPARATIVE BENCHMARKING SERVICES FOR SENIOR MANAGEMENT POSITIONS, AND OTHER INFORMATION ON COMPENSATION ISSUES, TRENDS, POLICIES, AND BEST PRACTICES FOR USE BY THE ORGANIZATION. THE ORGANIZATION ALSO HAS AN ESTABLISHED COMPENSATION POLICY FOR ALL OF ITS EMPLOYEES, WHICH SETS FORTH THE GENERAL PARAMETERS GOVERNING BIO'S COMPENSATION PRACTICES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. FORM 990, PART XI, LINE 9: CBI REVENUE 39,908. CBI LOBBYING FUND REVENUE 790,000. FOOD & AG INITIATIVES REVENUE 110,556. FOOD & AG LEGAL FUND REVENUE 16,219. FOOD & AG INITIATIVES EXPENSES -16,219. CBI LOBBYING FUND EXPENSE -834,447. BIOSIMILARS REVENUE 331,507. BIOSIMILARS EXPENSE -216,474.